| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  From Fauna For the People | For the Animals | For the World From Fauna is an international 501c3 nonprofit spreading awareness on cultivated meat (real meat made from cells instead of animals). Cellular Agriculture, Biotechnology, Agriculture, Cell Agriculture, CAS, Food Technology, and Biomaterials Type: | 0 | 0 | 0 | 9 |
 |  New Incentives New Incentives provides small cash incentives to increase childhood vaccinations and cost-effectively save lives. As a GiveWell top charity, New Incentives is dedicated to doing the most good per dollar donated. We are a US-based NGO that provides small cash incentives to caregivers (totalling approximately US$11) to vaccinate their infants against deadly, yet preventable diseases. We operate in northern Nigeria – a region with one of the lowest childhood vaccination rates in the world. We are recruiting: https://new-incentives.breezy.hr/ public health, immunizations, ngo, cash transfers, demand creation, Nigeria, Effective Altruism, GiveWell, vaccinations, startup, and health system strengthening Type: | 4 | 0 | 4 | 549 |
 | Logos Biosystems See beyond your cells. Advanced imaging solutions for research excellence. Logos Biosystems is the life science solutions of Aligned Genetics, Inc., dedicated to the development and commercialization of innovative technologies to support the life science research community. Since its founding in 2008, Logos Biosystems has been developing a series of automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis. Type: | 4 | 0 | 1 | 26 |
 | Bakkafrost Scotland Provenance. Passion. Respect. Bakkafrost Scotland (formerly The Scottish Salmon Company) is the leading producer of the finest quality Scottish salmon operating across the West Coast of Scotland and the Hebridean Islands. Exporting to over 20 countries from North America to the Far East, we have a growing reputation at home and abroad for producing the finest quality, sustainably raised Scottish Salmon. We are fully engaged in all stages of the value chain; from freshwater and marine farming through to processing and sales, ensuring full traceability and supply chain integrity. Unfortunately, we cannot respond to individual questions/posts directly on LinkedIn right … Type: | 3 | 1 | 0 | 193 |
 | Entocycle A world-leading provider of insect farms and insect farming technology. A world-leading provider of insect farms and insect technology • Our mission is to accelerate a global transition to sustainable protein, using insects and technology. Circular Economy, Clean Tech, Animal Feed, Zero Waste, Agritech, Insect Farming, and Insect Farming Technologies Type: | 8 | 1 | 7 | 40 |
 | BIOHM Nothing is ever-lasting. Everything is ever-changing. We do not design. We refine what nature has given us. Biohm is a multi-award winning research and development led company that is harmonising cultural and natural systems through the development and scaling of ground-breaking biotechnologies. Driven by the simple philosophy of allowing nature to lead innovation, Biohm redefines biomimicry as the holistic and systemic emulation of the multitudinous hierarchical systems in nature (the whole universe) to create intelligent solutions that are glocally situated, socially connected, and sensitive to the cybernetics and energetics of their environment. Biohm's biotechnologies, which are patented in almost 60 … Type: | 13 | 2 | 1 | 28 |
 | Mirnagreen Global leader in the field of plant microRNAs Mirnagreen is harnessing the power of natural MIRNA to generate super-charged applications to address and resolve the most pressing biological challenges of our time. MIRNA are small non-coding nucleic acids which exchange communication and instructions within and between organisms and are the products of millions of years of evolutionary refinement. Mirnagreen has developed the first proprietary platform for the large-scale extraction of natural MIRNA from biological sources and the development of products which make full use of their combinatorial biological efficacy. Natural MIRNA are destined to revolutionise life science applications from immune … Type: | 0 | 0 | 0 | 11 |
 |  D-EYE, Srl Disrupting retinal screening for medical purpose to improve people's quality of life D-EYE is changing medical care around the world by allowing healthcare professionals to quickly screen for problems, photograph and distribute them digitally via various secure wireless solutions. Our launch product is the low-cost, revolutionary Smartphone-Based Retinal Imaging System to promote earlier diagnosis of treatable eye conditions. This mobile health device is a combination of lenses and filters and a mobile app that turns a smartphone into a digital direct ophthalmoscope capable of recording high-definition video and still images of the posterior of the eye as well as transmitting … Tags: H2020 Type: | 2 | 0 | 1 | 3 |
 | Universal Diagnostics S.A. We will WIN the FIGHT against CANCER Universal Diagnostics S.A. (UDX) is a Spanish in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early. The UDX diagnostic platform is designed to detect various cancer types, e.g. colorectal, prostate, liver, pancreatic lung, breast cancer (>50% of all new cancer cases p.a.) via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected … | 3 | 1 | 1 | 112 |
 | Ascent Health Pharma supply chain company with automation & innovation to improve accessibility and affordable healthcare for all, What is Ascent? An organisation trying to consolidate an unorganized Pharma Distribution through: -Customer Delight -Process Automation -Operational Excellence -State of the art Infrastructure -Economies of Scale Why are we doing this? Ascent's inception took place with an idea of creating value within the pharmaceutical supply chain Our mission is to add some harmony among all the chaos and ensure affordability of health care to all What we do? PUTTING INDIAN HEALTHCARE FIRST! We aim to consolidate the fragmented pharma distribution business in India. … Type: | 0 | 0 | 0 | 179 |
 | Pragati Healthcare Pragati Healthcare India is a global exporter and distributor of Anti-cancer, Diabetes, Hepatitis, Cardiac, Sexual Health, HIV, Ophthalmic and OTC products. Our family has been into pharmaceutical distribution for over 50 years now and have significant presence in UK & Hong Kong. We have direct tie ups with reputed pharma companies like Pfizer, AstraZeneca, Novartis, Novo Nordisk, Eli Lilly, Bayer, Abbott, Boehringer Ingelheim, Sanofi, Sun Pharma, Natco, Cipla, Lupin, Intas and others. For other companies, we source from vendors after careful research about their repute and history. Cancer Medicines Exporter, Unlicensed Medicines, Parallel Exports, Europe Medicine Supplier, Named Patient Medication, … | 1 | 1 | 1 | 4 |
 | Interactive Scientific Making the Invisible Visible for Scientific Advancement Interactive Scientific want to open science to the world, and the world to science. Nano Simbox is an immersive scientific exploration product which is shaking up the way people think and learn about science. It’s used by researchers developing new drugs and by creative science teachers who want to bring learning alive in the classroom. Nano Simbox makes the invisible world visible, by mixing science, technology and creativity into a product that means you can actually see how molecules work and interact in the real world. Get in touch today to see how … Type: | 1 | 0 | 0 | 2 |
 | StaTwig Empowering Supply Chains with Blockchain-Powered Unit-Level Visibility and Transparency. Welcome to StaTwig, a leading SaaS startup dedicated to resolving critical supply chain challenges, including counterfeiting, black-marketing, and stockouts. Our innovative solutions capture the journey of every single unit of product, ensuring transparency and security throughout the supply chain. Our flagship product, VaccineLedger, is tailored for vaccine supply chains and has played a pivotal role in safeguarding the quality and safety of COVID-19 vaccines. Trusted by multiple health departments, VaccineLedger has received Digital Public Goods (DPGs) recognition from the United Nations Secretary General. Join us on our mission to revolutionize supply … Type: | 5 | 1 | 4 | 24 |
 |  RGL Research Supporting Healthcare Innovation R.G.L Research is a contract research organization (CRO) providing expertise and reliable support to the pharmaceutical industries for conducting Clinical Trials. Our clients and partners include pharmaceuticals, biotechnologies, startups, academic and government organization. R.G.L Research is providing tailored and quality services to help clients and partners bend the cost and time curve of drug development to deliver new alternative product and innovative treatment to improve patients quality of life. R.G.L Research has vast professional experience and academic knowledge in performing clinical trials in Israel as well as developing health product in diverse therapeutic areas of medicine, in … Type: | 2 | 1 | 1 | 0 |
 | Cortica Powering The Future With Autonomous AI Cortica is an Israeli company founded in 2007 with leading AI technology for autonomous platforms. The company’s Autonomous AI is based upon proprietary brain research and utilizes unsupervised-learning methodologies backed by more than 200 patents. The Cortica AI understands the visual world on a human level – thereby significantly exceeding the capabilities of the industry. This Autonomous AI is embedded in next-generation, ultra-scale platforms where understanding images is a critical task. Cortica provides the intelligence that enables autonomous vehicles, smart cities, autonomous drones, and more. With headquarters in Tel Aviv and offices in NYC, … Type: | 3 | 2 | 1 | 28 |
 | ValitaCell We create pioneering analytical technologies for quality control and performance for the biopharmaceutical industry. ValitaCell is a biotechnology company that creates and commercialises analytical products and technologies for the biopharmaceutical industry. Our products enable clients bring innovative medicines to the market faster, cheaper and with greater regulatory confidence. ValitaCell's vision is to become a pioneer in biological science and cell therapy and to harness the power of artificial intelligence for both applications. ValitaCell is now part of the Beckman Coulter Life Sciences company. Biotechnology , Biologics, Biopharmaceuticals, Bioprocessing, cell therapy, artificial intelligence, and deep learning Type: | 4 | 0 | 4 | 6 |
 | PLANTEDIT Our mission is to produce non-transgenic, regulatory free, sustainable, consumer oriented genome edited plant products. PLANTeDIT is the first biotech company dedicated to use patented next generation genome editing tools CRISPR/Cas9 RNPs® from our key collaborator Toolgen (http://toolgen.com/?lang=en) with our transformation technology for efficient direct delivery and swift regeneration of genome edited plants. Our mission is also to revolutionize plant transformation technology with our innovative, universal, cost effective, swift transformation system applicable to broad a range of crop species for direct delivery of genome editing tools. Further, PLANTeDIT aims to develop highly pure mammalian protein and human drugs at cost … Type: | 1 | 0 | 0 | 1 |
 | Nuritas See Nature Differently Through pioneering life science and artificial intelligence, we developed our unique Nuritas MagnifierNπΦ platform that allows us to identify, unlock, clinically test and patent peptides; turning them into powerful and precise ingredients that elevate natural efficacy. We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin. By translating nature’s wisdom into innovation, together, we can change the life of billions. Bioactive Peptide discovery and development, Pure peptides, Peptide mixtures, Hydrolysates, Multi targeted peptides, Bioinformatics, Artificial … Type: | 23 | 5 | 10 | 54 |
 | Medicines for Ireland Members of Medicines for Ireland supply the majority of medicines in Ireland to both the HSE and to patients directly Medicines for Ireland is an organisation founded and motivated by a strong desire to reform the way Ireland currently procures and supplies medicines. Many of the practices and approaches taken are no longer fit for purpose and are outdated. Achieving reform in this essential area of patient care is a core objective of our organisation. Email - info@medicinesforireland.ie Twitter - twitter.com/medicinesForIRL | 5 | 0 | 5 | 3 |
 | Hexafly Finding Smarter Ways to Feed the Planet Our Vision is to bring an Insect Farming revolution to the world, to end the overexploitation of land and ocean and to ultimately add to the progress of the human race. With revolutionary breeding and bio-conversion technologies, we maximise the extraction of high-value protein and oil products for the aquaculture, animal feed and plant nutrition industries. Our process produces no waste, lowers GHG emissions, optimises land usage, utilises industrial and agricultural waste streams and improves animal nutrition and health. We are ready to feed the world. Biotech, Liopids/Oils, Protein, Frass/Organic Fertilizer, AgriTech, BlackSoldierFly, … Type: | 6 | 3 | 1 | 12 |
 | Allogen Biotech Allogen Biotech is developing a portable food contamination and allergen-testing device that will enable food manufacturers and food processors bypass time consuming and expensive centralised laboratory testing. We are entering the worldwide and rapidly growing area of "Gluten-Free" (37% growth rate, UK) and "Free-From" (24% growth rate, UK) food manufacturing, and processing areas. Major market changes seen in the past few years include steadily increasing legislation on food labelling. This includes labelling specifically for allergens listed in foods. Recently there has been a European scandal involving equine derived DNA in products labelled as beef. This is a fine example of … Type: | 0 | 0 | 0 | 2 |
 | Next Generation Dublin-based recruitment agency | Life Sciences | Supply Chain & Procurement | Production | Engineering | Operations 💡 At Next Generation, we specialise in niche recruitment within Life Sciences and Food industries, extending our expertise to professionals in export-led manufacturing roles which encompass but are not limited to Quality, Engineering, Operations, Supply Chain, and Procurement. Our team of recruiters is extensively trained in the latest talent sourcing and attraction methods, including cutting-edge data mining techniques. This empowers us to assist our clients in enhancing their businesses by connecting them with top-tier professionals in these dynamic sectors while providing the most … Type: | 3 | 0 | 0 | 36 |
 | Cortechs At Cortechs, we are passionate about smart gaming designed around neuroscience. We use brain powered play and brainwaves as a tool to improve behaviours such as attention in easily distracted children that want to improve their focus. Check us out at www.cortechs.ie or follow us on Facebook and Twitter. Brain powered games for kids, Neuroscience, Brainwaves, and Healthy gaming Type: | 3 | 1 | 2 | 5 |
 | Helixworks Technologies Democratising synthetic DNA to enhance daily life around the world. Our mission is to democratise the power of DNA, enhancing daily life around the world. In pursuit of this goal, we make products that harness the remarkable capabilities of DNA. Custom Gene Synthesis, DNA sequence comparison and search tool, and Gibson Assembly® Ready Fragments for $19 only. Type: | 1 | 0 | 0 | 7 |
 | Oncopole [Automatic translation follows] Research, development and investment hub to accelerate cancer research in Quebec Research, development and investment hub to accelerate the fight against cancer. Type: | 9 | 2 | 7 | 16 |
 | Fraunhofer IZI-BB [Automatic translation follows] Fraunhofer Institute for Cell Therapy and Immunology, Bioanalytics and Bioprocesses Division **Current: Annual report 2023/2024 published** E-Paper: https://s.fhg.de/IZI-BB-JB Find out more about our vision for the future of the institute and about exciting innovations and new partnerships in the new annual report 2023/2024. With its expertise in analytics, diagnostics, biosystems engineering and biological safety, the Bioanalytics and Bioprocesses Division IZI-BB addresses promising and sustainable development areas. With a focus on biosensors, lab-on-a-chip technologies, miniaturization of biological processes and nanomaterials, we see great opportunities in the field of digital diagnostics and new possibilities for healthcare. We are determined … Type: | 2 | 0 | 2 | 46 |
 | German Center for Neurodegenerative Diseases (DZNE) Brain.Research.Life DZNE is a biomedical research institute dedicated to neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS. DZNE’s mission is to develop novel strategies for prevention, diagnosis, treatment, and care and to translate these into practice. DZNE operates 10 sites across Germany and cooperates with universities, university hospitals, and other institutions in Germany and abroad. It is government funded, a member of the Helmholtz Association and of the German Centers for Health Research. Like us on Facebook: www.facebook.com/dzne.de Follow us on Instagram: www.instagram.com/dzne_de Imprint: www.dzne.de/imprint Data privacy: www.dzne.de/datenschutz Neurodegeneration, Neuroscience, Dementia, Translation, Amyotrophic lateral sclerosis, Alzheimer's, Parkinson's, Huntington's, Ataxia, Lewy-Body-Disease, Hirnforschung, … Type: | 6 | 1 | 3 | 753 |
 | Pharma Intelligence, now Citeline We have a new page! Follow "Citeline, formerly Pharma Intelligence" to stay up to date on all our posts moving forward We have a new page! Follow "Citeline, formerly Pharma Intelligence" to stay up to date on all our new posts moving forward as we transition! From drug and device discovery and development to regulatory approval, drug reimbursement to lifecycle management – you need to make smart decisions that give you an advantage in a fast changing market. The pharma and healthcare sector is facing unparalleled upheaval: increasing pressures on research and development teams to show a better return on … Type: | 23 | 9 | 15 | 170 |
 | Curemark, LLC Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark’s pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson’s disease. | 1 | 0 | 1 | 23 |
 | PacBio Our mission is to enable the promise of genomics to better human health. At PacBio, we’re devoted to empowering you. Pioneering the future through biology takes vision. You have to look beyond the status quo to what’s possible. We know your vision can reveal the full potential of the genome, advance human health and the health of our planet. And that is why your vision and pursuit are at the very center of what our company does — our product design, our customer support model, our partnerships, and even our identity. We create the world’s most advanced sequencing systems to … Type: | 5 | 1 | 3 | 694 |
 | Owlstone Medical On a mission to save 100k lives and $1.5B healthcare costs Owlstone Medical is developing a breathalyzer for disease. With a goal of finding ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health, and other conditions. Our mission is to save 100,000 lives and $1.5B in healthcare costs by advancing early detection and precision medicine. Breath Biopsy® aims to develop a new diagnostic modality making it possible to discover novel non-invasive biomarkers in breath using a platform with the potential to transition to point-of-care. The award-winning ReCIVA® Breath Sampler ensures the reliable collection of breath samples. … Type: | 14 | 3 | 10 | 203 |
 | Ontario Genomics We are a not-for-profit dedicated to connecting & collaborating to advance genomics technologies & research in Ontario Ontario Genomics is a not-for-profit organization incorporated in the province of Ontario. Ontario Genomics receives funding from the Ontario government, Genome Canada and other public and private partners for strategic initiatives. Established in 2000, our mission is to lead the application of genomics-based solutions across key sectors of the economy to drive economic growth, improved quality of life and global leadership for Ontario. Our vision is to enable healthy people, a healthy economy and a healthy planet through genomics innovations. We work with … Type: | 14 | 0 | 13 | 24 |
 | Seratec [Automatic translation follows] Your CDMO for API solutions since 1970 | Our excellence, your trust #OEYT At Seratec, APIs are more than a science. They are a passion. Entrepreneurs in pharmaceutical chemistry since 1970, we produce active pharmaceutical ingredients (APIs) for the treatment of rare and orphan diseases. With internationally recognized French know-how, we design, develop, produce and register dossiers for pharmacologically active molecules with the American (FDA), European (EMA) and national (ANSM) drug agencies. To offer the best services, we also ensure the production of APIs according to the quality standards known as Good Manufacturing Practices (GMP 2 or … Type: | 9 | 0 | 9 | 26 |
 | ASTRUM CRO France (formerly POPSI CUBE) Agile Clinical & Digital Pan European Contract Research Organization (CRO) We are a Pan European Clinical Contract Research Organization (CRO), We offer to our Pharmaceutical, Biotech and Medtech partners a complete outsourcing of their clinical trials from phase I to phase IV by integrating the entirety of the value creation chain of medical product development activity. The origin of Popsi Cube is a convergence between a solid clinical process and effective IT tools. A CRO with integrated tools to address the entire clinical research functional scope. A successful project management requires top quality human resources but also a set of … Type: | 0 | 0 | 0 | 19 |
 | Holodiag API Characterization, Polymorphism, Screening & Crystallization Process Holodiag is a Contract Research Organization founded in 2006 dedicated to solid state and crystallization processes of small molecules, mainly APIs. We provide our customers with: ¤ Analytical characterizations: Holodiag is equipped with XRPD, DSC, TGA, DVS, FTIR, Laser PSD, IDR and more. All analyses are available on toxic samples down to 50 ng/m3. ¤ Solid state investigations: Screenings of polymorphs, salts, co-crystals. Properties investigations on stability, solubility, dissolution. ¤ Crystallization processes: Development from scratch, optimization of existing process, trouble shooting. Investigations on product recovery, isomer separation, filtration, drying, particle engineering, control of … | 0 | 0 | 0 | 12 |
 | BioSpeedia BioSpeedia is a biotechnology company founded by two scientific researchers from Institut Pasteur. BioSpeedia was founded by 2 renowned scientists from the Institut Pasteur in 2011: Evelyne Begaud, President and Yves Germani, Chief Scientific Officer. Our clinical research is conducted at St-Priest-en-Jarez, France and clinical testing and quality control in Paris and St. Etienne, France. BioSpeedia is also in the process of relocating part of its overseas production to France. Our global sales and distribution, product registration in various jurisdictions, liasing with regulatory authorities, logistics and shipping is handled by our distribution arm, BioVitess Ltd. which is located in Belfast, … Type: | 2 | 1 | 0 | 2 |
 | Alchemab Therapeutics Ltd Pioneering Patient-led Antibody Therapeutics Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development. Alchemab takes an unbiased and function-first approach using three complementary processes and cutting-edge technologies to identify naturally protective antibodies. Alchemab’s engine is enabled through collaborations with patient representative groups and biobanks around the world with whom we partner to further our understanding of disease. Antibody Therapies, Immunology, and Neuro-dengeneration Type: | 4 | 1 | 3 | 59 |
 | HemostOD Inspired by platelet biology to save lives. We engineer and manufacture platelets. platelets, biotechnology, bioengineering, stem cells, on demand, biodrug, in vitro manufacturing, Bioprocess, blood platelets, alloimmunization, thrombocytopenia, blood cancer, leukemia, transfusion, HSCT, Stem cell, Hematology, biologics, drug, biopharma, drug development, healthcare, allogenic therapy, drug delivery, miRNA, siRNA, targeted delivery, and targeted drug delivery Type: | 2 | 0 | 0 | 9 |
 | BioPorto Diagnostics A/S BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem. The Company’s flagship products are based on the NGAL biomarker and designed … Type: | 0 | 0 | 0 | 47 |
 | Tiziana Life Sciences Tiziana Life Sciences LTD is a NASDAQ listed (NASDAQ:TLSA) clinical stage biotechnology company Tiziana Life Sciences LTD is a biotechnology company focused on transformational technology enabling alternative routes for immunotherapy . https://www.tlsainfo.com/ | 1 | 0 | 1 | 8 |
 | Bright Peak Therapeutics Better Biologics Through Chemistry Bright Peak are developing a portfolio of first-in-class and best-in-class cytokines with optimized biological properties for the treatment of cancer and autoimmune diseases. Through a variety of proprietary technology platforms, Bright Peak is uniquely abled to conjugate its cytokines as payloads to antibodies, creating bespoke, novel and proprietary “Bright Peak Immunocytokines”, and to other cytokines as “duokines”. The Bright Peak Immunocytokines allow tissue- and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy. One of the many advantages of our approach is its "off-the-shelf" feature. Using a pioneering site-specific ADC-like chemical … Type: | 1 | 0 | 0 | 55 |
 | Augustine Therapeutics Innovative Therapies for Neuromuscular and Neurodegenerative Disorders Augustine Therapeutics focuses on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT), peripheral neuropathies and neurodegenerative disorders. The company is rooted in the ground-breaking research at VIB and KU Leuven and supported by Asabys Partners, Eli Lilly and Company, V-Bio Ventures, PMV, AdBio Partners, VIB, Gemma Frisius Fund and CMT Research Foundation. ——— *Disclaimer* ——— We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge … Type: | 0 | 0 | 0 | 15 |
 | Medannex Ltd Award-winning Scottish biopharmaceutical company, advancing the treatment of cancers and autoimmune diseases. Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1. Our goal is to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. Following a recent Series B fundraise, and supported by both the Scottish Investment Bank and Innovate UK, Medannex is collaborating with world-leading clinical experts to explore the huge therapeutic and commercial potential of our patent-protected immunomodulatory technology. Antibody development, Innovation, Biotechnology, T cell modulation, Skills development, Autoimmune diseases, Inflammation, Lupus, SLE, Collaboration, … Type: | 2 | 0 | 2 | 10 |
 | Herantis Pharma Plc. Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s. Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease. Herantis’ lead product HER-096, is an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein. It combines the compelling mechanism of action of CDNF with the convenience of subcutaneous administration. A Phase 1a clinical trial has demonstrated a good safety and tolerability profile, and efficient blood-brain barrier penetration of subcutaneously administered HER-096 in humans. The shares of Herantis are listed on the Nasdaq First … Type: | 1 | 0 | 1 | 21 |
 | OmicsChart Multi-Omics for Translational Cancer Research OmicsChart is a computational cancer biology startup revolutionising translational cancer research with our proprietary multi-omics cancer biomarker discovery platform. Our platform enables rapid access and analysis of harmonised biomarker data for 35 cancer indications through domain-specific AI and machine learning, reducing data acquisition and analysis time by 150 times compared to current practices. Our solution allows translational cancer scientists to quickly test hypotheses and extract insights from a harmonised mix of public and proprietary biomarker data. Built on federated data integration and domain-driven ML/AI, our platform features biologist-friendly scientific visualisations. We provide comprehensive insights on … Type: | 7 | 0 | 1 | 4 |
 | Saventic Health AI-driven diagnosis of rare diseases We are a med-tech company that creates artificial intelligence algorithms to support doctors in diagnosing rare (hidden) diseases early based on patients' medical records i.e. laboratory test results, radiology and other descriptive medical data. artificial intelligence, AI, healthcare diagnostic, healthcare, precision medicine, rare diseases, oncology, hemathology, clinical decision support tools, clinical decision support system, Blood cancers, Rare blood & marrow diseases, Metabolic storage diseases, Immune system disorders, and Skin & tissue diseases Type: | 0 | 0 | 0 | 42 |
 | e-therapeutics PLC Computing the future of medicine A specialist in computational drug discovery with a focus on developing RNA interference (“RNAi”) therapeutics Type: | 0 | 0 | 0 | 52 |
 | PharmNovo Innovation in pain relief PharmNovo AB is a clinical-stage pharmaceutical company focused on developing safe and effective drugs for neuropathic pain. In this area, there is currently a lack of sufficient treatments. The company’s drug candidate, PN6047, effectively reduces neuropathic pain in animal models and the findings from the Phase I trial show that PN6047 is safe and well-tolerated at the doses tested, with no serious adverse events reported. Furthermore, PN6047 exhibited none of the adverse events typically associated with the conventional opioids like oxycodone and morphine, such as respiratory depression, constipation, itching, or signs of abuse potential. This validates … Type: | 0 | 0 | 0 | 10 |
 | CellCentric Developing inobrodib (CCS1477), first-in-class p300/CBP inhibitor to treat specific cancers. Inobrodib is the first small molecule drug in the clinic targeting twin proteins p300 and CBP. It is formulated as a capsule taken orally. p300/CBP are twin (paralogue) acetyl transferases, and importantly, gene activating proteins that are known to play an important role in the progression of certain cancers. CellCentric’s pioneering drug is in Phase I/II clinical trials to evaluate its effectiveness to treat specific solid tumours, as well as haematological malignancies (blood cancers). These represent major clinical unmet needs, delivering a new therapy for people with cancer, who otherwise … Type: | 2 | 1 | 1 | 23 |
 | 4D Biomaterials 4Degra® 3D printing biomaterials - helping people heal. Regenerative, resorbable and customisable. The market for polymeric biomaterials is growing quickly, but despite this growth, it is widely recognised in the industry that the ‘holy grail’ solution has not yet been developed. The ideal biomaterial for use in regenerative medicine must: be biocompatible; promote tissue regeneration; have non-toxic biodegradation, have mechanical properties suited to the host tissue and good handling properties in a clinical environment. Our people have developed a patented range of novel polymeric 3-D printing resin-inks that promise, uniquely, to meet all of the above requirements and offer important … Type: | 0 | 0 | 0 | 9 |
 | ARGONAUTE RNA LIMITED Argonaute RNA Ltd. is developing safe and reliable methods of temporarily silencing target genes in different tissue cells. Argonaute RNA is pursuing a number of therapeutic opportunities in RNA interference. RNAi harnesses a cell mechanism that inhibits the expression of a specific gene and thereby inhibits the production of a specific protein. Argonaute RNA research projects build on existing intellectual property. We show how our proprietary modification of small interfering RNA (siRNA) allows safe and effective ways to silence specific gene expression. We use a novel method of stabilising the siRNA and thereby avoid a range of issues which have … Type: | 0 | 0 | 0 | 10 |
 | Integra Therapeutics Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases At Integra Therapeutics we have combined the precision of CRISPR systems with the gene transfer efficiency of viral integrases and transposases. Harnessing what nature has evolved to introduce large pieces of DNA into the genome, together with the precision of sequence specific DNA binding proteins, has allowed for unprecedented efficiency in programmable gene delivery. Type: | 2 | 1 | 1 | 20 |
 | PolyModels Hub 🧬 Accelerate drug development with modeling, simulations, and data 💻 PolyModels Hub kicked off in late 2022 with a mission: make modeling in Life Sciences easier for everyone and boost innovation. We started right here on Linkedin, building a community by sharing the latest research and open-source tools for life sciences. We are strong advocates for open-source modeling – it's akin to the transformation we saw in Software Dev and AI. That's why we recently introduced our open-source Hub, where you can sign up to discover, build and connect with the open-source community! Fast forward to 2024, and we decided … Type: | 0 | 0 | 0 | 6 |
 | Draupnir Bio Bringing innovative therapies to patients Draupnir Bio is a Danish biotechnology company driven by a deep commitment to scientific excellence and the desire to bring innovative therapies to patients in need. By harnessing the natural machinery of the lysosome, we are developing oral, small molecule degraders of extracellular pathogenic proteins – the next frontier of targeted protein degradation (TPD), a rapidly emerging field that exploits a cell’s own destruction machinery to tackle disease-causing proteins that have historically been highly challenging to target with conventional therapies. First-generation TPD approaches are exclusively limited to intracellular targets, leaving extracellular and membrane-bound proteins – … Type: | 0 | 0 | 0 | 16 |
 | Pan Cancer T Pan Cancer T is a biotechnology company developing T cell receptor (TCR) T-cell therapy for solid tumors. Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies. We exploit the 20 years of pioneering in adoptive T cell therapy as a springboard to breakthrough treatment of solid tumors. Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors, and make T cell therapy maximally accessible despite the tumor micro-environment challenges. Type: | 1 | 1 | 0 | 9 |
 | SciRhom Targeting iRhom2 for better treatment of autoimmune diseases SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening diseases. Founded in late 2016, we develop first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signalling pathways, including TNF-alpha signalling. Following the preclinical and early clinical development of these monoclonal antibodies, we are aiming to provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. SciRhom is poised to transform the lives of patients with autoimmune diseases. drug … Type: | 3 | 2 | 2 | 16 |
 | Asceneuron SA Targeting the root cause of neurodegeneration Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases including orphan tauopathies, Alzheimer’s and Parkinson’s disease. Asceneuron has two clinical stage small molecule O-GlcNAcase inhibitors in development for the treatment of proteinopathies including Parkinson’s Disease, Alzheimer’s disease and related disorders. Asceneuron is a privately held company financed by a renowned syndicate of investors consisting of Sofinnova Partners, M Ventures, SR One, Johnson & … Type: | 3 | 2 | 2 | 20 |
 | Akadeum Life Sciences, Inc. Better Isolations. Healthier Cells. Akadeum Life Sciences® has developed a next generation platform that solves long-standing problems across cell therapy and other research, diagnostic and therapeutic markets. The proprietary buoyant microbubble technology platform addresses the need for high cell quality, scalability, time and workflow that current magnetic particle-based products commonly used in cell therapy manufacturing and research can’t address. The Company has several GMP grade and Clinical Ready kits to enable each stage of cell therapy manufacturers pipeline. Harnessing the microbubble capability, the AlerionTM Microbubble Cell Separation System enables cell isolation from tens of billions of cells in apheresis material … Type: | 1 | 1 | 0 | 31 |
 | Genomenon, Inc Genomic intelligence for clinical diagnostics and precision medicine development Genomenon is a leading genomic intelligence company dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer. Blending the power of AI with genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development. The company’s solutions include software, data, and services. Genomenon offers advanced genomic software solutions designed to streamline and enhance genetic research and clinical decision-making. Our flagship product, the Mastermind® Genomic Intelligence Platform, provides comprehensive genomic data integration and analysis, offering researchers and clinicians … Type: | 1 | 1 | 0 | 145 |
 | SwaLife Biotech At Swalife Biotech, we are at the forefront of developing next-generation therapies for cancer and chronic diseases. Our research is rooted in the discovery of five novel bioactive alkaloids from plants, aimed at synthesizing compounds that target key mechanisms in skin and breast cancer. We leverage cutting-edge technologies such as network pharmacology and AI to enhance our understanding and development of drug therapies. Our alkaloids have shown promising results in inhibiting the DNA Damage Response (DDR) pathway, crucial in preventing drug resistance and cancer cell survival. Our innovative approach not only targets cancer but also extends to managing chronic diseases, … Type: | 0 | 0 | 0 | 3 |
 | Mello Enabling probiotics and bioactives for healthier, more sustainable solutions of tomorrow Mello aims to enable the powerful effect of probiotics and bioactives so that they can be used to enhance your health and wellbeing. We're pioneering a groundbreaking encapsulation ?technology securing unparalleled effectiveness in the human body. Our unique delivery solutions will solve the longstanding challenge of delivering bioactives, to a specific target location in the body, effectively. Probiotic encapsulation, micro-encapsulation, and Encapsulation technology Type: | 1 | 1 | 0 | 9 |
 | Turbine We are building the world’s leading predictive simulation of patient biology. Truly meaningful medicine comes from breakthroughs?in deeply understanding patient biology. We are building the world’s leading predictive simulation of patient biology. We will empower the biopharma industry by informing the right experiments that identify and validate disease driving hidden effects. Drug Discovery, Biotechnology, Artificial Intelligence, in silico, Cell Biology, Simulated Experiments, Bioinformatics, and Pharmaceuticals Type: | 5 | 0 | 5 | 101 |
 | Insilico Medicine #insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. artificial intelligence, deep learning, reinforcement learning, drug discovery, … Type: | 20 | 2 | 17 | 295 |
 | Caura Everything car. All in one place. Caura is making car admin easy - welcome to an entirely new way to manage #AllThingsCar! So far, we've raised $4.2m in 2021 from investors such as TwinFocus and InMotion Ventures (the investment arm of Jaguar Land Rover). In 2023, we secured a £4m from Lloyds Banking Group and partnered with MoneySuperMarket to offer competitive car insurance With Caura, you can: - Keep up to date on vehicle compliance with key reminders straight to your phone - Find the best insurance deals and manage your policy in-app - Book vehicle maintenance at over 6,000+ … Type: | 2 | 2 | 0 | 35 |
 | Unmind Wellbeing that works. Creating a world where mental health is universally understood, nurtured, and celebrated. Unmind is the workplace wellbeing platform on a mission to create mentally healthy workplaces, where everyone can flourish. We partner with some of the world’s biggest brands (like Major League Baseball, Nationwide, Disney, Standard Chartered, Mediacom and British Airways) to give over 2.5 million people the right support at the right time. Unlike 95% of wellbeing solutions, we’re built on science. We take a whole organisation approach, giving people at all levels the tools they need to thrive. Psychology, Workplace Wellness, Health & Wellbeing, Mental … Type: | 21 | 4 | 18 | 214 |
 | Puraffinity We Protect Environmental & Human Health by Engineering Targeted Materials to Capture Chemicals Puraffinity is a spinout company from Imperial College London that specialises in designing and manufacturing novel advanced materials for environmental benefit, such as removing harmful pollutants from water and wastewater. Focusing initially on PFAS removal, Puraffinity has developed an innovative adsorbent media allowing an easily deployable solution for addressing PFAS compliance. In addition, the solution is highly cost effective, providing an attractive Return On Investment for customers, and reduced life-cycle costs. Founded in 2015, Puraffinity is backed by leading sustainability investors Kindred Capital, Heritage Group Ventures and … Type: | 10 | 1 | 6 | 38 |
 | The Medicine Maker The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form Type: | 29 | 6 | 27 | 1 |
 | Aridhia – Digital Research Environment – DRE A world-class Digital Research Environment that delivers for Life Science, Academia and Research Delivering the Aridhia Digital Research Environment (DRE), the trusted, secure, self-service, cloud-enabled digital research environment for biomedical, precision medicine and healthcare researchers Aridhia DRE delivers secure, auditable workspaces for research teams to engage personally, collaboratively and productively around data from multiple systems and sources in order to address complex data challenges. Commit to Rapid, Efficient and Collaborative Innovation Driven by Data. Aridhia DRE makes it easy to assemble your people, tools and data assets in secure, open source analytic workspaces to accelerate data-driven projects like never before. … Type: | 15 | 0 | 9 | 59 |
 | Immunocore Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI Type: | 9 | 3 | 1 | 538 |
 | Crescendo Biologics Limited Crescendo Biologics - The T cell Enhancing Company Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical … Type: | 5 | 3 | 4 | 50 |
 | Togetherall An anonymous, accessible and safe place to support each other We’ve spent more than 16 years building a safe online community for members to take control, get support, and feel better. People come to Togetherall for support with a wide range of mental health and wellbeing issues – from anxiety, depression, loneliness, isolation, and stress, to relationship problems, and other life challenges. The safety of our members and clinical rigour is at the core of what we do, and we have a network of licensed mental health practitioners providing 24/7/365 support around the world. ✔ Peer-to-peer community– giving and receiving … Type: | 0 | 0 | 0 | 67 |
 | Newcells Biotech Ltd In vitro models to accelerate clinical translation We’re here to accelerate your therapy’s journey through the complexities of drug discovery and development. Putting innovation at the forefront of our capabilities, industry-leading experts help you confidently and proactively answer critical questions around the safety and efficacy of your product with our gold-standard in vitro models. By harnessing the power of predictive data, we navigate this crucial step efficiently and cost-effectively to maximise the potential of your therapy achieving clinical and market success. By combining our unique expertise with cutting-edge technologies, we’ve created predictive in vitro models that offer targeted solutions to … Type: | 1 | 0 | 1 | 47 |
 | Genomics plc Transforming health, healthcare and drug discovery through the power of genomics We are a pioneering healthcare company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalized estimates of risk for all the common diseases and cancers, well ahead of … Type: | 12 | 4 | 11 | 148 |
![LCC [Liverpool ChiroChem]](/media/logo/101424.jpeg){kind=logo} | LCC [Liverpool ChiroChem] Bring new compounds to market faster, better, and easier. Liverpool ChiroChem is an international, chemical technology innovator, on a mission to accelerate the discovery and development of high-quality drugs. LCC was established in Liverpool, United Kingdom, in June 2014. The company has developed a suite of synthetic methodologies that have been used to produce thousands of novel, multifunctional 3D-rich, chiral fragments/scaffolds/BB’s to support NCE discovery & development (e.g. Fragments, DEL, VLS, Bifunctional Linkers). LCC is continuously expanding its 3D chemical space and has recently launched a 1.4Bn member Ultra-Large Virtual Library designed based on its proprietary scaffolds and supported by … Type: | 2 | 0 | 0 | 30 |
 | Evox Therapeutics Ltd Naturally inspired. Engineered to deliver Evox Therapeutics is harnessing and engineering the natural trafficking capabilities of extracellular vesicles to develop an entirely novel class of biotherapeutics. By combining groundbreaking exosome technology from well-renowned Oxford University and the Karolinska Institutet – the home of the Nobel Prize – we aim to revolutionise the treatment of a broad range of severe disease, with profound implications for human health. Based in Oxford, UK, Evox Therapeutics was founded in 2016 by Professor Matthew Wood of Oxford University, Assistant Professor Samir EL Andaloussi and Dr Per Lundin of the Karolinska Institutet, to capitalise on foundational … Type: | 6 | 2 | 0 | 53 |
 | Perspectum Ltd Unmatched, integrated data intelligence Perspectum's imaging solutions are safe, fast, and can offer more comprehensive diagnostics. We help doctors understand complex data and help deliver precision care to more patients. We believe the voice of the patient matters and that each case is unique. Our goal is to enable health care providers to tailor precision medicine to the needs of the individual. Medical Software Development, Medical image analysis, Medical Physics, Clinical trials, and Multiparametric MRI Type: | 11 | 2 | 6 | 272 |
 | Closed Loop Medicine Treating the individual, not just the disease, through personalized and optimized dosing. We need to shift to a world where we treat the individual, not just the disease. Our inventions work in combination with medicine to deliver personalized, optimized dosing, to provide bespoke universal healthcare access and improve outcomes for patients with chronic diseases. Closed Loop Medicine is a TechBio company developing combination prescription drug + software products, with the aim of bringing forward the promise of precision care. Our proprietary technology platform facilitates personalized drug dose optimization through integration of medicines and software with patient-led digital experiences and closed … Type: | 10 | 1 | 5 | 54 |
 | Sensio Air Type: | 1 | 1 | 0 | 4 |
 | McSAF Chemical tools for bioconjugaison & biodrugs McSAF is a Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry, developing innovative technologies for improved targeted therapies. Its core expertise covers Therapeutic Peptides and Proteins, Antibodies, and Drug Conjugates. The team has a strong background in synthetic selective chemistry, and a real expertise in bioconjugation, including specific designs of Antibody Drug Conjugates (ADCs) with own proprietary coupling technology. Plus, the company has now a pipeline of three products in oncology incorporating McSAF Inside technology with the ambition to bring new biodrugs on the market solving unmet medical needs. Bioconjugation, Biopharmaceuticals, Antibody Drug Conjugates, … Type: | 1 | 1 | 0 | 6 |
 | MTPConnect We are Australia's Life Sciences Innovation Accelerator. We are Australia's Life Sciences Innovation Accelerator championing the continuing growth of Australia's vibrant medical products sector. Connect with our newsletter: https://www.mtpconnect.org.au/newsletter Subscribe to our podcast: https://podcasts.apple.com/au/podcast/the-mtpconnect-podcast/id1453637211 Medical technology, Biotechnology, Pharmaceutical, Collaboration, and Commercialisation Type: | 22 | 1 | 21 | 47 |
 | MOLTOX We manufacture products used in genetic toxicology, industrial microbiology, environmental biology and molecular biology Founded in Maryland and later settled in the beautiful Blue Ridge Mountains of North Carolina, since 1986 MOLTOXTM has been and continues to be a leading manufacturer of products used in Genetic Toxicology, Industrial Microbiology, Environmental Biology and Molecular Biology. Through the dedication and commitment of our longstanding team, we have assisted customers around the world in their pursuit of testing, research and development in each of these fields. Our customers have come to rely on the MOLTOXTM name for our high quality products and continued … Type: | 3 | 1 | 2 | 9 |
 | Molecular Devices Advancing Discovery Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over … Type: | 3 | 1 | 2 | 765 |
 | MedTech Europe From diagnosis to cure MedTech Europe’s mission is to make innovative medical technology available to more people, while helping healthcare systems move towards a sustainable path. MedTech Europe encourages policies that help the medical technology industry meet Europe’s growing healthcare needs and expectations. It also promotes medical technology’s value for Europe focusing on innovation and stakeholder relations, using economic research and data, communications, industry events and training sessions. MedTech Europe started as an alliance in October 2012 formed by two organisations - EDMA, representing the European in vitro diagnostic industry; and Eucomed, representing the European medical devices industry. Promoting a … Type: | 33 | 12 | 20 | 115 |
 | Viridos See how algae moves us. Viridos is a privately held biotechnology company harnessing the power of photosynthesis to create transformative solutions to mitigate climate change. Our unparalleled understanding of algal genetics and ability to translate innovation from lab to field underpins our initial deployment: a scalable platform to produce low-carbon intensity biofuels for aviation, commercial trucking, and maritime shipping. Building on a legacy of genomic firsts, our team of scientists and engineers are shaping new pathways toward a sustainable bioeconomy. To learn more, visit us at Viridos.com. Synthetic Biology, Fermentation, Next Generation Genomics, Bioprocessing, Bioinformatics, Cell Optimization, Biodiscovery, Advanced Engineering, … Type: | 5 | 0 | 5 | 83 |
 | Medicines Discovery Catapult Reshaping drug discovery for patient benefit. Independent, not-for-profit national innovation centre for drug discovery. We collaborate with UK medicines discovery and diagnostics organisations, giving them access to expertise, technology, and high-quality data. We accelerate their progress, precision drugs get to clinical trials more rapidly, and patients get life-improving medicines earlier than they otherwise would have. biotechnology, pharma, medicines discovery, biotech, pharmaceuticals, drug discovery, tissue samples, discovery science and technology, virtual research and development, mass spectrometry, complex cell models, clinical data, biomarkers, tissue imaging, drug delivery, target engagement, target validation, omics, drug research, and Neuroscience Type: | 14 | 4 | 11 | 194 |
 | Medicago La santé est dans notre nature | Health is in our nature. Medicago develops vaccines and treatments to help fight emerging global health challenges, today and in the future. Please note that we may come across a situation not outlined above that will require the removal of your comment. Please know that Medicago reserves the right to delete any comment at its sole discretion. If you feel your comment has been unfairly removed, please contact us. For information about our commenting guidelines, please visit: http://ow.ly/6mKh50HKyUR Medicago développe des vaccins et des traitements pour répondre rapidement aux nouveaux défis de santé … Type: | 5 | 0 | 1 | 180 |
 | Materials Design, Inc. Atomistic Modeling and Simulation Software and Consulting Materials Design, Inc. is the leader in computational materials engineering on atomic scale. Our solutions successfully serve the needs of leading industrial, academic and research customers across diverse industrial applications such as semiconductors, chemicals, oil & gas, materials for automotive, aerospace, power generation and many more. Using our MedeA® high performance modeling environment, you will complement and focus your experiments and traditional materials models to gain a deeper understanding of your materials, to rapidly assess a broad range of properties, and to efficiently evaluate improvement scenarios. MedeA® brings together an integrated suite of … Type: | 3 | 0 | 4 | 39 |
 | Nexstim We enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim is a Finnish, globally operating medical technology company. Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of … Type: | 0 | 0 | 0 | 48 |
 | Europhartech - A Dômes Pharma Company [Automatic translation follows] Europhartech, a company of the Dômes Pharma Group Production site of the Dômes Pharma Group EUROPHARTECH is also a CMO (Contract Manufacturing Organization) for the Human and Veterinary Pharmaceutical Industry. Specialized in clinical batches, the production of dry forms and non-sterile liquid forms for human and veterinary use as well as in food supplements, complementary foods and medical devices. EUROPHARTECH also has solid expertise in the originator markets, ATU/AMM hospital and EHPAD unit BUD, PDA, generic and nutraceutical. EUROPHARTECH is a subsidiary of the DÔMES PHARMA Pharmaceutical Group historically specialized in Animal Health and present in Human … Type: | 2 | 1 | 0 | 75 |
 | Institut Bergonié [Automatic translation follows] Cancer Center of Nouvelle-Aquitaine #research #innovation #care #cancerprevention Founded in 1923, the Bergonié Institute has been a private healthcare institution of collective interest since May 20, 2010. It is also one of the 18 cancer centers. Located in the town of Bordeaux, it is the only cancer center in Nouvelle-Aquitaine and, with the Bordeaux University Hospital, constitutes the regional cancer center. The Bergonié Institute is labeled "integrated cancer research site" (SIRIC) by the National Cancer Institute (INCa). A member of the UNICANCER group, it is the bearer of a cancer model based on multidisciplinarity, individualization of treatments … Type: | 26 | 12 | 12 | 539 |
 | Fondation Toulouse Cancer Santé [Automatic translation follows] Research is moving forward, thanks to you, with us. #CancerTousConcernés Created in 2005, Toulouse Cancer Santé is a medical research foundation against cancer, serving the Oncopole of Toulouse. Recognized as being of public utility, the Toulouse Cancer Santé Foundation supports innovative projects and promotes collaborations between teachers, researchers, doctors and entrepreneurs. The cooperation thus established within the Oncopole makes it possible to enrich the means and skills and to the benefit of the fight against cancer. Type: | 25 | 2 | 24 | 5 |
 | C4X Discovery Ltd Pioneering drug discovery company exploiting cutting edge technologies to create best-in-class small molecule medicines C4XD is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world‐leading medicines. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced molecular design and patient stratification capabilities, generating small molecule drug candidates across multiple disease indications focused on immuno-inflammation. The Company was founded as a spin-out from the University of Manchester. It has a highly experienced management team and Board who have delivered significant value creation within the healthcare sector historically and have enabled C4XD … Type: | 7 | 1 | 4 | 47 |
 | Overleaf LaTeX, simplified. Write like a rocket scientist with Overleaf —the collaborative, online LaTeX editor anyone can use. Overleaf is the scientific and technical writing platform loved by over 16 million users around the world. It's a LaTeX editor that’s easy enough for beginners and powerful enough for experts. Using Overleaf, anyone can write smarter—creating complex, beautifully formatted documents with ease. But more than that, it lets you collaborate easily with colleagues, track changes in real-time, write in LaTeX code or a visual editor, and work anywhere, on any device. Plus, with personal, group, and institutional options, right up to on-premises … Type: | 5 | 1 | 0 | 81 |
 | IntelliDigest Empowering Global Food Sustainability. IntelliDigest is a purpose driven company that is empowering global food sustainability through technology innovation and capacity building. Our cutting-edge research and innovative technology solutions are enabling businesses in the food system from farm to fork to become more sustainable; improving the way we grow food, distribute and consume food while eliminating edible food waste and upcycling inedible food waste back into the food system in the most efficient way to grow more nutritious food locally. Through knowledge exchange and capacity building, we are providing awareness to stakeholders in the food system and policy makers on … Type: | 15 | 1 | 11 | 15 |
 | Re:Cognition Health We provide specialist cognitive healthcare services & support clinical trial patient recruitment at our UK & USA clinics We are recognised for our award-winning private mental health services, covering neurology, psychology and psychiatry. We treat a range of conditions, including: ADHD, Autism, Alzheimer's disease, Parkinson's disease, migraine and mild Traumatic Brain Injury. As part of our work as a world-leading memory clinic, we also undertake ongoing Alzheimer’s research and trials in partnership with global pharmaceutical companies. Our expertise and commitment to successful clinical trial patient recruitment is driven by our dedication to better dementia and memory loss outcomes and, ultimately, … Type: | 1 | 1 | 1 | 130 |
 | Topivert Pharma Limited TopiVert is a clinical-stage biotechnology company developing next-generation, Narrow Spectrum Kinase Inhibitors (NSKIs) as novel, non-systemic medicines for the treatment of chronic inflammatory diseases of the gastrointestinal (GI) tract and the eye. The lead GI programme TOP1288 is currently in a Phase IIa proof of concept study in ulcerative colitis. A Phase I/II study with TOP1630 for dry eye syndrome will commence in the US in early 2017. NSKI, ulcerative colitis, kinase inhibitors, and ophthalmology Type: | 1 | 1 | 0 | 3 |
 | Aqdot Limited The Supramolecular Chemistry Company Aqdot is a Cambridge (UK)-based supramolecular chemistry company with a focus and expertise in developing, licensing and selling novel proprietary products. The Aqdot Solutions part of the business works in partnership with customers to understand their challenges and develop solutions utilising the unique AqBit technology. This has the team working in areas from air filtering in transportation to delivery of therapeutics for cancer. In parallel the Aqdot Products part of the company has recently launched its own brands AqStarTM M1 and Oderase to date. Again, working with partners either on a distribution basis, or offering the … Type: | 2 | 1 | 1 | 30 |
 | CytoSeek A cell-therapy technology company developing artificial membrane-binding proteins for oncology and regenerative medicine CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies. Our novel cell membrane augmentation technology enables us to add new functionalities to various therapeutic cells. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health. Biochemistry, Immunology, Oncology, Regenerative Medicine, Cell therapies, and Proteins Type: | 0 | 0 | 0 | 2 |
 | Phytoponics Ltd No longer trading No longer trading hydroponics, aeroponics, agriculture, vertical farming, agtech, horticulture, and innovation | 3 | 1 | 0 | 0 |
 | MindX (acquired by HireVue) In May 2018, MindX was acquired by HireVue, a Carlyle portfolio company. MindX was founded in 2014 as a next generation predictive hiring & talent analytics platform, integrating the latest advancements in psychometrics, game tech, and machine learning / AI. Companies used MindX's software to identify the best talents and reduce bias / increase diversity whilst streamlining and automating their hiring process. In May 2018, MindX was acquired by HireVue, who shared a similar mission: MindX and HireVue have teamed up to bring together two leading-edge approaches to pre-hire assessment: game-based assessment and video-based assessment. Together, we provide the most … Type: | 11 | 0 | 11 | 1 |
NGO, Think-tanks, Ed, & Culture